VIVAGLOBIN Trademark

Trademark Overview

On Tuesday, March 20, 2007, a trademark application was filed for VIVAGLOBIN with the United States Patent and Trademark Office. The USPTO has given the VIVAGLOBIN trademark a serial number of 79037920. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, March 20, 2017. This trademark is owned by ZLB Behring GmbH. The VIVAGLOBIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, immunoglobulins, plasma and blood products and products derived from blood and recombinant DNA technology
vivaglobin

General Information

Serial Number79037920
Word MarkVIVAGLOBIN
Filing DateTuesday, March 20, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, March 20, 2017
Registration Number3427149
Registration DateTuesday, May 13, 2008
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 26, 2008

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations, namely, immunoglobulins, plasma and blood products and products derived from blood and recombinant DNA technology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCSL Behring GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameZLB Behring GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
Address35041 Marburg
DE
Party NameZLB Behring GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
Address35041 Marburg
DE

Trademark Events

Event DateEvent Description
Friday, November 3, 2017UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, October 13, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, October 13, 2017DEATH OF INTERNATIONAL REGISTRATION
Thursday, February 25, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 2, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 9, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 9, 2015INVALIDATION PROCESSED
Wednesday, August 19, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 19, 2014CANCELLED SECTION 71
Sunday, February 10, 2013NEW REPRESENTATIVE AT IB RECEIVED
Sunday, December 30, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 19, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, September 4, 2008FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 4, 2008FINAL DISPOSITION PROCESSED
Thursday, August 14, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 13, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, February 26, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2008NOTICE OF PUBLICATION
Friday, January 18, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 18, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 17, 2008AMENDMENT FROM APPLICANT ENTERED
Thursday, January 17, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 16, 2008ASSIGNED TO LIE
Friday, November 30, 2007PAPER RECEIVED
Friday, July 20, 2007REFUSAL PROCESSED BY IB
Friday, June 29, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 29, 2007REFUSAL PROCESSED BY MPU
Friday, June 29, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 28, 2007NON-FINAL ACTION WRITTEN
Thursday, June 28, 2007ASSIGNED TO EXAMINER
Friday, June 8, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, June 7, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

vivaglobin products blood from recombinant technology derived preparations immunoglobulins plasma pharmaceutical